Anzeige
Meldung des Tages: Gold bei 5.250 USD – Dieser 37-Mio.-€-Goldentwickler sitzt auf einem möglichen $2-Milliarden-Projekt!!

Bausch Health News

Aktie
WKN:  A2JQ1X ISIN:  CA0717341071 US-Symbol:  BHC Branche:  Pharmazeutika Land:  Kanada
4,6405 €
-0,006 €
-0,13%
12:13:59 Uhr
Depot/Watchlist
Marktkapitalisierung *
2,26 Mrd. €
Streubesitz
22,33%
KGV
-67,17
Index-Zuordnung
-

Bausch Health News

23.02.26 - PR Newswire
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada PR Newswire
19.02.26 - PR Newswire
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres PR Newswire
18.02.26 - PR Newswire
BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS PR Newswire
17.02.26 - PR Newswire
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference PR Newswire
11.02.26 - PR Newswire
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program PR Newswire
23.01.26 - PR Newswire
Bausch Health Provides Update on RED-C Phase 3 Clinical Trials
Bausch Health Provides Update on RED-C Phase 3 Clinical Trials PR Newswire
21.01.26 - PR Newswire
Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026
Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026 PR Newswire
05.01.26 - PR Newswire
Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference PR Newswire
11.09.25 - PR Newswire
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-​stage Liver Disease Portfolio PR Newswire
29.07.25 - PR Newswire
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease PR Newswire

Newssuche

Videos

newspaper
10.03.26 -5,92%
Technical Trading: DAX Long Chance
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »